Syndopa CR 125 Tablet is used to manage the symptoms of Parkinson’s disease and other movement disorders. It effectively reduces muscle rigidity, tremors, and the slowing of physical movements, allowing for better motor coordination. This medication is crucial for helping patients perform daily tasks with greater ease and maintaining a higher quality of life over the long term.
This medication contains a combination of Levodopa and Carbidopa in a controlled-release (CR) formulation. Levodopa is converted into dopamine in the brain to restore neurochemical balance, while Carbidopa prevents Levodopa from being broken down before it reaches the brain. The controlled-release mechanism provides a steady supply of these chemicals, reducing the ""on-off"" fluctuations often seen with standard therapy.
This tablet must be taken exactly as scheduled by your doctor to maintain consistent movement control. Do not crush or chew the tablet, as this will destroy the controlled-release property. Consult your healthcare provider if you experience sudden mood changes, hallucinations, or unusual involuntary movements.



















































































